U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385951) titled 'Spatial Navigation for the Early Detection of Alzheimer's Disease' on April 3.
Brief Summary: Alzheimer's Disease (AD) is the most common form of dementia and may contribute to 60-70 % of all cases. An early, accurate diagnosis of AD will become increasingly important with disease-modifying therapies. Different types of fluid and neuroimaging biomarkers are available for the early detection of AD. However, implementation of routine use of these biomarkers in clinical settings is held back due to the risk of overdiagnosis, increased cost and invasiveness of the assessment method. Therefore, novel biomarkers are needed beyond the amy...